To access this course, you need to be logged in/registered. Click here to continue.

Dosage effects of dexmedetomidine on postoperative nausea and vomiting in female patients undergoing thoracoscopic radical lung cancer surgery.

Expiry Date
: 06/06/2029
CPD Units
: 3.00 Points
Rating
: Not yet rated.

The authors aimed to clarify the clinical efficacy and explore the optimal dose of dexmedetomidine in female patients undergoing thoracoscopic radical lung cancer surgery.

Keywords: postoperative nausea and vomiting, thoracoscopic surgery, dexmedetomidine, lung cancer

Reading material:

Educational Objectives

Educational Aim:
To clarify the clinical efficacy and explore the optimal dose of dexmedetomidine in female patients undergoing thoracoscopic radical lung cancer surgery. 

Educational Outcomes:
Upon completion of this module practitioners should have a clear understanding of:

    1. Factors influencing postoperative nausea and vomiting 

    1. Previous treatment methods and the need for a new suitable medication for postoperative nausea and vomiting 

    1. Understanding the dosage effects of dexmedetomidine on postoperative nausea and vomiting in female patients undergoing thoracoscopic radical lung cancer surgery. 

Instructions for this Module

  • Read the supplied reading material and complete the quiz that follows;
  • You have three attempts to pass the quiz;
  • The pass grade is 70%;
  • You need to pass the quiz to claim your CPD certificate;
  • Please click on the CPD certificate link below to claim your CPD certificate and to update your CPD Manager.

If you need any assistance to complete this module, please Contact us